Liuzhou Chemical Industry Co., Ltd. (SHA:600423)
China · Delayed Price · Currency is CNY 2.520
+0.020 (0.80%)
Nov 10, 2026, 11:19 AM CST
Liuzhou Chemical Industry Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 144.05 | 135.46 | 163.9 | 140.84 | 139.81 | 122.59 |
Other Revenue | 1.95 | 1.95 | 0.99 | 1.06 | 0.65 | 4.7 |
| 146.01 | 137.41 | 164.89 | 141.9 | 140.46 | 127.29 | |
Revenue Growth | -1.53% | -16.67% | 16.20% | 1.03% | 10.35% | 18.83% |
Cost of Revenue | 116.91 | 129.33 | 129.83 | 114.57 | 116.03 | 101.64 |
Gross Profit | 29.09 | 8.07 | 35.06 | 27.33 | 24.43 | 25.65 |
Selling, General & Admin | 12.68 | 11.95 | 11.61 | 9.17 | 8.27 | 10.84 |
Research & Development | 0.51 | 0.47 | 1.29 | 3.21 | - | - |
Other Operating Expenses | 0.98 | 0.5 | 0.71 | 0.36 | 0.65 | 0.78 |
Operating Expenses | 14.07 | 12.88 | 13.91 | 12.78 | 8.99 | 11.36 |
Operating Income | 15.02 | -4.8 | 21.15 | 14.55 | 15.44 | 14.29 |
Interest Expense | -0.15 | -0.19 | -0.21 | -0.04 | - | - |
Interest & Investment Income | 12.29 | 13.24 | 13.86 | 13.79 | 14.09 | 13.47 |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | 0 | 0 | 0.01 | -0 |
Other Non Operating Income (Expenses) | -0.12 | -0.08 | -0.09 | -0 | -0 | -0.02 |
EBT Excluding Unusual Items | 27.03 | 8.16 | 34.72 | 28.3 | 29.54 | 27.74 |
Merger & Restructuring Charges | - | - | - | - | - | -0.01 |
Gain (Loss) on Sale of Assets | - | - | 0.02 | - | -0.28 | 2.04 |
Asset Writedown | -36.75 | -37.3 | -0.72 | - | - | - |
Legal Settlements | -0.98 | -0.98 | -5.11 | -0.33 | -0.5 | -1.47 |
Other Unusual Items | 0.29 | 0.29 | 0.67 | 45.28 | -12.9 | 0.53 |
Pretax Income | -10.41 | -29.83 | 29.58 | 73.25 | 15.86 | 28.81 |
Income Tax Expense | -1.28 | -4.12 | -0.6 | -0 | - | - |
Earnings From Continuing Operations | -9.13 | -25.71 | 30.18 | 73.25 | 15.86 | 28.81 |
Net Income | -9.13 | -25.71 | 30.18 | 73.25 | 15.86 | 28.81 |
Net Income to Common | -9.13 | -25.71 | 30.18 | 73.25 | 15.86 | 28.81 |
Net Income Growth | - | - | -58.81% | 361.97% | -44.97% | 126.60% |
Shares Outstanding (Basic) | 863 | 857 | 754 | 814 | 793 | 720 |
Shares Outstanding (Diluted) | 863 | 857 | 754 | 814 | 793 | 720 |
Shares Change | 16.45% | 13.61% | -7.31% | 2.66% | 10.06% | 13.30% |
EPS (Basic) | -0.01 | -0.03 | 0.04 | 0.09 | 0.02 | 0.04 |
EPS (Diluted) | -0.01 | -0.03 | 0.04 | 0.09 | 0.02 | 0.04 |
EPS Growth | - | - | -55.56% | 350.00% | -50.00% | 100.00% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 9.23 | 3.56 | 45.88 | 2.32 | 18.48 | 5.05 |
Free Cash Flow Per Share | 0.01 | 0.00 | 0.06 | 0.00 | 0.02 | 0.01 |
Gross Margin | 19.93% | 5.88% | 21.26% | 19.26% | 17.40% | 20.15% |
Operating Margin | 10.29% | -3.49% | 12.83% | 10.25% | 10.99% | 11.23% |
Profit Margin | -6.25% | -18.71% | 18.30% | 51.62% | 11.29% | 22.64% |
Free Cash Flow Margin | 6.32% | 2.59% | 27.82% | 1.63% | 13.16% | 3.96% |
EBITDA | 26.53 | 6.25 | 31.6 | 22.48 | 22.89 | 21.93 |
EBITDA Margin | 18.17% | 4.55% | 19.16% | 15.84% | 16.30% | 17.23% |
D&A For EBITDA | 11.5 | 11.05 | 10.45 | 7.93 | 7.45 | 7.64 |
EBIT | 15.02 | -4.8 | 21.15 | 14.55 | 15.44 | 14.29 |
EBIT Margin | 10.29% | -3.49% | 12.83% | 10.25% | 10.99% | 11.23% |